Corpus Intelligence IC Memo — ESSENTIA HEALTH MOOSE LAKE 2026-04-26 12:48 UTC
IC Memo — ESSENTIA HEALTH MOOSE LAKE
Investment Committee Memorandum | MN | 25 beds | Grade C | EBITDA uplift $2.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ESSENTIA HEALTH MOOSE LAKE

CCN 241350 | CARLTON, MN | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ESSENTIA HEALTH MOOSE LAKE is a 25-bed rural/critical access in CARLTON, MN with $38.1M in net patient revenue and a -5.0% operating margin. The hospital serves a payer mix of 42.7% Medicare, 6.9% Medicaid, and 50.4% commercial.

Thesis: Turnaround. Our ML models identify $2.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.0% to 2.4% (+736bps).

Net Revenue HCRIS$38.1M
Current EBITDA COMPUTED$-1.9M
Operating Margin COMPUTED-5.0%
Occupancy HCRIS30.7%
Revenue / Bed COMPUTED$1.5M
Net-to-Gross HCRIS58.5%
Distress Probability ML56.4%

2. Market Context & Competitive Position

141
MN Hospitals
-3.6%
State Median Margin
92
Comparable Hospitals

MN has 141 Medicare-certified hospitals with a median operating margin of -3.6%. The target's margin of -5.0% places it below the state median. Among 92 size-comparable peers (12-50 beds), the median margin is -2.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 92 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ESSENTIA HEALTH MOOSE LAKE (Target)MN25$38.1M-5.0%
CUYUNA REGIONAL MEDICAL CENTERMN25$180.8M-4.0%
ST. MARYS REGIONAL HEALTH CENTMN36$167.8M3.1%
MAYO CLINIC HEALTH SYSTEM - REMN27$149.3M1.8%
ESSENTIA HEALTH VIRGINIAMN49$132.0M-5.0%
NEW ULM MEDICAL CENTERMN24$128.6M4.2%
LAKEWOOD HEALTH SYSTEMMN25$124.7M0.2%
NORTHFIELD CITY HOSPITALMN37$121.8M-8.4%
GRAND ITASCA CLINIC AND HOSPITMN34$117.7M5.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$800K+210bp18mo
Cost to Collect4.5%2.5%$762K+200bp12mo
Denial Rate Reduction12.0%6.5%$754K+198bp12mo
A/R Days Reduction5200.0%3800.0%$464K+122bp9mo
Clean Claim Rate88.0%96.0%$24K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$800K
Cost to Collect
$762K
Denial Rate Reduction
$754K
A/R Days Reduction
$464K
Clean Claim Rate
$24K
Total EBITDA Uplift$2.8M
Current EBITDA$-1.9M
+ RCM Uplift+$2.8M
Pro Forma EBITDA$905K
Current Margin-5.0%
Pro Forma Margin2.4%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-2.9M$15.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-2.9M$16.1M0.00x-100.0%
Bull Case9.0x11.0x$-2.6M$24.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.6M$25.9M0.00x-100.0%
Bear Case11.0x10.0x$-3.2M$2.4M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.2M$1.6M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 30.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 56.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 92 hospitals with 12-50 beds
  • Same-state prioritization (n=93)
  • Comp margins: P25=-9.7% / P50=-2.0% / P75=3.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.